BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6729204)

  • 21. Omeprazole.
    Maton PN
    N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
    Okabe S; Shimosako K; Amagase K
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 26. Omeprazole.
    Med Lett Drugs Ther; 1990 Mar; 32(813):19-21. PubMed ID: 2179694
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole.
    Oberg K; Lindström H
    Lancet; 1983 Jan; 1(8314-5):66-7. PubMed ID: 6129395
    [No Abstract]   [Full Text] [Related]  

  • 30. A turnover model of irreversible inhibition of gastric acid secretion by omeprazole in the dog.
    Abelö A; Eriksson UG; Karlsson MO; Larsson H; Gabrielsson J
    J Pharmacol Exp Ther; 2000 Nov; 295(2):662-9. PubMed ID: 11046103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of omeprazole on insulin induced gastric secretion in man.
    Utley RJ; Wright R; Beastall GH; Carter DC
    Scott Med J; 1985 Apr; 30(2):96-100. PubMed ID: 3892679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA; Boyd EJ; Wormsley KG
    Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man.
    Kittang E; Aadland E; Schjønsby H
    Gut; 1985 Jun; 26(6):594-8. PubMed ID: 3924748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety aspects of omeprazole.
    Sölvell L
    Scand J Gastroenterol Suppl; 1986; 118():129-35. PubMed ID: 3460168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [4 weeks' administration of omeprazole: effect on acid behavior and basal hormone levels].
    Müller P; Seitz HK; Simon B; Dammann HG; Feurle G; Huefner M; Lichtwald K; Schmidt-Gayk H
    Z Gastroenterol; 1984 May; 22(5):236-40. PubMed ID: 6741200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Omeprazole treatment in the Zollinger-Ellison syndrome].
    Bardram L; Stage JG; Stadil F
    Ugeskr Laeger; 1985 Mar; 147(10):867-9. PubMed ID: 3984061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.